Martina LombardiMartina Lombardi is currently serves as Chief Scientific Officer at Theoreo srl, a spin-off company of the University of Salerno that deals with metabolomics, specifically the use of metabolomic profiling for the development of screening tests for huan diseases. She also works at the "AOU Ruggi D'aragona" University Hospital in Salerno, Italy, where she was awarded a fellowship in internal medicine to study specifically the mechanisms underlying the progression of non-alcoholic fatty liver disease (NAFLD) and its association with metabolic syndrome and cardiovascular risk. She has published various papers in international peer-reviewed journals and presented her research results at metabolomic and bioinformatics and computational biology international conferences. She is currently actively engaged in the development of screening tests based on metabolomic profiling for various diseases, focusing mainly on oncological diseases and is part of the scientific committee of a national conference on applications of metabolomic profiling in endometrial cancer screening. Read More Read Less